scholarly article | Q13442814 |
P50 | author | Lian Zhao | Q87812027 |
P2093 | author name string | Juan Ding | |
Li Tian | |||
Shaojun Liu | |||
Anliu Tang | |||
Feiyan Ai | |||
Liyang Zhang | |||
Minghao Wu | |||
Wuliang Tang | |||
Zhiheng Chen | |||
P2860 | cites work | MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma | Q21245768 |
Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2 | Q24608490 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL) | Q24629558 | ||
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer | Q27851634 | ||
Worms gang up on bacteria | Q27860588 | ||
Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
Cancer statistics, 2013 | Q27860762 | ||
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
MicroRNA in cancer prognosis | Q28304380 | ||
Cancer epigenetics comes of age | Q29617275 | ||
Cytosine methylation and the ecology of intragenomic parasites | Q29618264 | ||
DNA hypermethylation in tumorigenesis: epigenetics joins genetics | Q33870798 | ||
Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer | Q33952921 | ||
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer | Q34718013 | ||
Genetics, cytogenetics, and epigenetics of colorectal cancer | Q34758641 | ||
Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis. | Q35227134 | ||
MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6. | Q35479487 | ||
Review article: colorectal cancer chemotherapy | Q35544078 | ||
Retracted: MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma | Q35598357 | ||
Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer | Q35601474 | ||
STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells | Q35619400 | ||
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10. | Q35781552 | ||
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1 | Q35853031 | ||
Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. | Q36232847 | ||
The fundamental role of epigenetics in hematopoietic malignancies | Q36373780 | ||
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia | Q36437006 | ||
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. | Q37262433 | ||
miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis | Q37519422 | ||
Metastasis mechanisms | Q37580464 | ||
Epidemiology of gastrointestinal and liver tumors. | Q37760164 | ||
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? | Q38053397 | ||
Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins | Q38288017 | ||
miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma | Q38888825 | ||
MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1. | Q38890422 | ||
MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer | Q38893838 | ||
miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer | Q38947535 | ||
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells | Q38980750 | ||
miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer | Q39017343 | ||
miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. | Q39101541 | ||
STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells | Q39389781 | ||
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. | Q39460209 | ||
TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. | Q39592007 | ||
Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival | Q39890752 | ||
MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3. | Q40036237 | ||
Genomic imprinting: significance in development and diseases and the molecular mechanisms | Q41197290 | ||
The role of DNA methylation in cancer genetic and epigenetics | Q41291310 | ||
How does DNA methylation repress transcription? | Q41653866 | ||
LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway | Q48428083 | ||
MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. | Q50953133 | ||
MicroRNA-124 regulates neuronal differentiation of mesenchymal stem cells by targeting Sp1 mRNA. | Q52978378 | ||
The fundamental role of epigenetic events in cancer | Q56421597 | ||
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients | Q60895640 | ||
RNA and the epigenetic regulation of X chromosome inactivation | Q74557357 | ||
P433 | issue | 35 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 38139-38150 | |
P577 | publication date | 2015-10-15 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. | |
P478 | volume | 6 |
Q47946930 | Current research on circular RNAs associated with colorectal cancer |
Q58772425 | Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer |
Q59806405 | Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer |
Q88258482 | Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types |
Q91903963 | Inferring novel genes related to colorectal cancer via random walk with restart algorithm |
Q92323764 | Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition |
Q55007797 | Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer. |
Q38769734 | Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation |
Q38721848 | MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma |
Q91783137 | MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression |
Q37059641 | MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression |
Q38768751 | MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein |
Q64089099 | MicroRNA‑124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3 |
Q39069897 | Mutual regulation of microRNAs and DNA methylation in human cancers |
Q37052433 | Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma |
Q98287691 | Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy |
Q91785720 | Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network |
Q37604381 | Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells |
Q92221539 | Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials |
Q36992190 | Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). |
Q26740283 | The emerging role of miR-506 in cancer |
Q57047259 | The mir-200 family regulates key pathogenic events in ascending aortas of individuals with bicuspid aortic valves |
Q37564425 | The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer. |
Q47879638 | UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4. |
Q38598443 | mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation |
Q61811949 | miR-124, a potential therapeutic target in colorectal cancer |
Q38798902 | miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3. |
Q58553627 | miR-506 attenuates methylation of lncRNA to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3 |
Q55310838 | miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer. |
Search more.